Acanthamoeba keratitis: An emerging disease gathering importance worldwide?

Trends in Parasitology

Volumn 29, Issue 4, 2013, Pages 181-187

  Lorenzo Morales, Jacob ^a   Martín Navarro, Carmen M ^a   López Arencibia, Atteneri ^a   Arnalich Montiel, Francisco ^b   Piñero, José E ^a   Valladares, Basilio ^a  

^a UNIVERSIDAD DE LA LAGUNA   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Acanthamoeba; Diagnosis; Emerging disease; Keratitis; Therapy

Indexed keywords

ANTIAMEBIC AGENT; BIGUANIDE; CHLORHEXIDINE; CORTICOSTEROID; DIBROMPROPAMIDINE; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; NEOMYCIN; PROPAMIDINE ISETHIONATE; PROTEINASE;

ACANTHAMOEBA KERATITIS; CELL DEATH; CONTACT LENS; CYST; HOST CELL; HUMAN; INCIDENCE; INFECTION RISK; NONHUMAN; PATHOGENESIS; REVIEW;

ACANTHAMOEBA; ACANTHAMOEBA KERATITIS; CONTACT LENSES; HUMANS; INCIDENCE; RISK FACTORS;

ACANTHAMOEBA;

EID: 84875535727     PISSN: 14714922     EISSN: 14715007     Source Type: Journal    
DOI: 10.1016/j.pt.2013.01.006     Document Type: Review

References (79)

1. Visvesvara G.S., et al. Pathogenic and opportunistic free-living amoebae: Acanthamoeba spp., Balamuthia mandrillaris, Naegleria fowleri, and Sappinia diploidea. FEMS Immunol. Med. Microbiol. 2007, 50:1-26.
2. Dart J.K., et al. Acanthamoeba keratitis: diagnosis and treatment update 2009. Am. J. Ophthalmol. 2009, 148:487-499.
3. Lorenzo-Morales J., et al. Acanthamoeba isolates belonging to T1, T2, T3, T4 and T7 genotypes from environmental freshwater samples in the Nile Delta region, Egypt. Acta Trop. 2006, 100:63-69.
4. Caumo K., et al. Potentially pathogenic Acanthamoeba in swimming pools: a survey in the southern Brazilian city of Porto Alegre. Ann. Trop. Med. Parasitol. 2009, 103:477-485.
5. Edagawa A., et al. Isolation and genotyping of potentially pathogenic Acanthamoeba and Naegleria species from tap-water sources in Osaka, Japan. Parasitol. Res. 2009, 105:1109-1117.
6. Siddiqui R., Khan N.A. Biology and pathogenesis of Acanthamoeba. Parasit. Vectors 2012, 5:6.
7. Lorenzo-Morales J., et al. Therapeutic potential of a combination of two gene-specific small interfering RNAs against clinical strains of Acanthamoeba. Antimicrob. Agents Chemother. 2010, 54:5151-5155.
8. Bonilla-Lemus P., et al. Acanthamoeba spp. in domestic tap water in houses of contact lens wearers in the metropolitan area of Mexico City. Exp. Parasitol. 2010, 126:54-58.
9. Stockman L.J., et al. Prevalence of Acanthamoeba spp. and other free-living amoebae in household water, Ohio, USA: 1990-1992. Parasitol. Res. 2010, 108:621-627.
10. Lorenzo-Morales J., et al. Pathogenic Acanthamoeba strains from water sources in Jamaica, West Indies. Ann. Trop. Med. Parasitol. 2005, 99:751-758.
11. Lorenzo-Morales J., et al. Isolation and identification of pathogenic Acanthamoeba strains in Tenerife, Canary Islands, Spain from water sources. Parasitol. Res. 2005, 95:273-277.
12. Liang S.Y., et al. Isolation and identification of Acanthamoeba species related to amoebic encephalitis and nonpathogenic free-living amoeba species from the rice field. J. Appl. Microbiol. 2010, 109:1422-1429.
13. Niyyati M., et al. Isolation and genotyping of potentially pathogenic Acanthamoeba strains from dust sources in Iran. Trans. R. Soc. Trop. Med. Hyg. 2009, 103:425-427.
14. Niyyati M., et al. Genotyping of Acanthamoeba isolates from clinical and environmental specimens in Iran. Exp. Parasitol. 2009, 121:242-245.
15. Astorga B., et al. Acanthamoeba belonging to T3, T4, and T11: genotypes isolated from air-conditioning units in Santiago, Chile. J. Eukaryot. Microbiol. 2011, 58:542-544.
16. Dyková I., et al. Acanthamoeba strains isolated from organs of freshwater fishes. J. Parasitol. 1999, 85:1106-1113.
17. Walochnik J., et al. Isolation and identification by partial sequencing of the 18S ribosomal gene of free-living amoebae from necrotic tissue of Basilliscus plumifrons (Sauria: Iguanidae). Parasitol. Res. 1999, 85:601-613.
18. Schuster F.L., Visvesvara G.S. Free-living amoebae as opportunistic and non-opportunistic pathogens of humans and animals. Int. J. Parasitol. 2004, 34:1001-1027.
19. Visvesvara G.S., et al. Isolation, morphologic, serologic and molecular identification of Acanthamoeba T4 genotype from the liver of a Temminck's tragopan (Tragopan temminckii). Vet. Parasitol. 2010, 170:197-200.
20. Kent M., et al. Multisystemic infection with an Acanthamoeba sp in a dog. J. Am. Vet. Med. Assoc. 2011, 238:1476-1481.
21. Chappell C.L., et al. Standardized method of measuring Acanthamoeba antibodies in sera from healthy human subjects. Clin. Diag. Lab. Immunol. 2001, 8:724-730.
22. Brindley N., et al. Acanthamoeba castellanii: high antibody prevalence in racially and ethnically diverse populations. Exp. Parasitol. 2009, 121:254-256.
23. Kiderlen A.F., et al. Balamuthia and Acanthamoeba-binding antibodies in West African human sera. Exp. Parasitol. 2010, 126:28-32.
24. Sadaka H.A., Emam E.E. Is the intestinal tract a portal of entry for Acanthamoeba infection?. J. Egypt. Soc. Parasitol. 2001, 31:781-790.
25. Steinberg J.P., et al. Disseminated acanthamebiasis in a renal transplant recipient with osteomielitis and cutaneous lesions: case report and literature review. Clin. Infect. Dis. 2002, 35:E43-E49.
26. Dickson J.M., et al. Acanthamoeba rhinosinusitis. J. Otolaryngol. Head Neck Surg. 2009, 38:E87-E90.
27. Panjwani N. Pathogenesis of Acanthamoeba keratitis. Ocul. Surf. 2010, 8:70-79.
28. Naginton J., et al. Amoebic infection of the eye. Lancet 1974, 2:1537-1540.
29. Samples J.R., et al. Acanthamoeba keratitis possible acquired from a hot tub. Arch. Ophthalmol. 1984, 102:707-710.
30. Radford C.F., et al. Acanthamoeba keratitis in England and Wales: incidence, outcome, and risk factors. Br. J. Ophthalmol. 2002, 86:536-542.
31. Van Klink F., et al. The role of contact lenses, trauma, and Langerhans cells in a Chinese hamster model of Acanthamoeba keratitis. Invest. Ophthalmol. Vis. Sci. 1993, 34:1937-1944.
32. Ormonde S. The plague that won't simply go away: Acanthamoeba keratitis. Clin. Exp. Ophthalmol. 2009, 37:155-157.
33. Patel D.V., et al. Resurgence of Acanthamoeba keratitis in Auckland, New Zealand: a 7-year review of presentation and outcomes. Clin. Exp. Ophthalmol. 2010, 38:15-20.
34. Bryant K., et al. Acanthamoeba keratitis - multiple states, 2005-2007. MMWR Morb. Mortal. Wkly. Rep. 2007, 1:532-534.
35. Ku J.Y., et al. Acanthamoeba keratitis cluster: an increase in Acanthamoeba keratitis in Australia. Clin. Exp. Ophthalmol. 2009, 37:181-190.
36. Carvalho F.R.S., et al. Twenty years of Acanthamoeba keratitis. Cornea 2009, 28:516-519.
37. Verani J.R., et al. National outbreak of Acanthamoeba keratitis associated with use of a contact lens solution, United States. Emerg. Infect. Dis. 2009, 15:1236-1242.
38. Tu E.Y., Joslin C.E. Recent outbreaks of atypical contact lens-related keratitis: What have we learned?. Am. J. Ophthalmol. 2010, 150:602-608.
39. Joslin C.E., et al. The association of contact lens solution use and Acanthamoeba keratitis. Am. J. Ophthalmol. 2007, 144:169-180.
40. Shoff M.E., et al. Efficacy of contact lens systems against recent clinical and tap water Acanthamoeba isolates. Cornea 2008, 27:713-719.
41. Thebpatiphat N., et al. Acanthamoeba keratitis: a parasite on the rise. Cornea 2007, 26:701-706.
42. Hasler S., et al. MoisturePlus contact lens solution as a source of Acanthamoeba keratitis. Cornea 2009, 28:219-220.
43. Shoff M., et al. Variable responses of Acanthamoeba strains to three multipurpose lens cleaning solutions. Optom. Vis. Sci. 2007, 84:202-207.
44. Martín-Navarro C.M., et al. Acanthamoeba spp.: efficacy of Bioclen FR One Step, a povidone-iodine based system for the disinfection of contact lenses. Exp. Parasitol. 2010, 126:109-112.
45. Imayasu M., et al. Effects of multipurpose contact lens care solutions on the adhesiveness of Acanthamoeba to corneal epithelial cells. Eye Contact Lens 2009, 35:246-250.
46. Lim N., et al. Comparison of polyhexamethylene biguanide and chlorhexidine as monotherapy agents in the treatment of Acanthamoeba keratitis. Am. J. Ophthalmol. 2008, 145:130-135.
47. Ferrari G., et al. Double-biguanide therapy for resistant Acanthamoeba keratitis. Case Reports Ophthalmol. 2011, 2:338-342.
48. Martín-Navarro C.M., et al. The potential pathogenicity of chlorhexidine-sensitive Acanthamoeba strains isolated from contact lens cases from asymptomatic individuals in Tenerife, Canary Islands, Spain. J. Med. Microbiol. 2008, 57:1399-1404.
49. Kliescikova J., et al. Propylene glycol and contact-lens solutions containing this diol induce pseudocyst formation in Acanthamoebae. Exp. Parasitol. 2011, 127:326-328.
50. Kilvington S. Antimicrobial efficacy of a povidone iodine (PI) and a one-step hydrogen peroxide contact lens disinfection system. Contact Lens Anterior Eye 2004, 27:209-212.
51. Sun X., et al. Acanthamoeba keratitis: clinical characteristics and management. Ophthalmology 2006, 113:412-416.
52. Alizadeh H., et al. Role of contact lens wear, bacterial flora, and mannose-induced pathogenic protease in the pathogenesis of amoebic keratitis. Infect. Immun. 2005, 73:1061-1068.
53. Khan N.A. Acanthamoeba biology and increasing importance in human health. FEMS Microbiol. Rev. 2006, 30:564-595.
54. Sharma S., et al. Patient characteristics, diagnosis, and treatment of non-contact lens related Acanthamoeba keratitis. Br. J. Ophthalmol. 2000, 84:1103-1108.
55. Seal D.V., et al. Acanthamoeba keratitis. Br. J. Ophthalmol. 2003, 87:516-517.
56. Garg P., et al. Microbial keratitis after LASIK. J. Refract. Surg. 2010, 26:209-216.
57. Sharma D.P., et al. Microbial keratitis after corneal laser refractive surgery. Future Microbiol. 2011, 6:819-831.
58. Arnalich-Montiel, F. et al. (2012) Co-isolation of Vahlkampfia and Acanthamoeba in Acanthamoeba-like keratitis in a Spanish population. Cornea, doi:10.1097/ICO.0b013e31825697e6.
59. Arnalich-Montiel F., et al. Mixed Acanthamoeba and multidrug-resistant Achromobacter xyloxidans in late-onset keratitis after laser in situ keratomileusis. J. Cataract. Refract. Surg. 2012, 38:1853-1856.
60. Stehr-Green J.K., et al. The epidemiology of Acanthamoeba keratitis in the United States. Am. J. Ophthalmol. 1989, 107:331-336.
61. Clarke D.W., Niederkorn J.Y. The pathophysiology of Acanthamoeba keratitis. Trends Parasitol. 2006, 22:175-180.
62. Patel D.V., McGhee C.N.J. Acanthamoeba keratitis: a comprehensive photographic reference of common and uncommon signs. Clin. Exp. Ophthalmol. 2009, 37:232-238.
63. Lorenzo-Morales J., et al. Acanthamoeba keratitis due to genotype T11 in a rigid gas permeable contact lens wearer in Spain. Contact Lens Anterior Eye 2011, 34:83-86.
64. Da Rocha-Azevedo B., et al. Diagnosis of infections caused by pathogenic free-living amoebae. Interdiscip. Perspect. Infect. Dis. 2009, 2009:251406.
65. Vaddavalli P.K., et al. Role of confocal microscopy in the diagnosis of fungal and Acanthamoeba keratitis. Ophthalmology 2011, 118:29-35.
66. Itahashi M., et al. Utility of real-time polymerase chain reaction in diagnosing and treating Acanthamoeba keratitis. Cornea 2011, 30:1233-1237.
67. Lee J.E., et al. Cysticidal effect on Acanthamoeba and toxicity on human keratocytes by polyhexamethylene biguanide and chlorhexidine. Cornea 2007, 26:736-741.
68. Amoils S.P., Heney C. Acanthamoeba keratitis with live isolates treated with cryosurgery and fluconazole. Am. J. Ophthalmol. 1999, 127:718-720.
69. Schuster F.L., et al. In vitro activity of miltefosine and voriconazole on clinical isolates of free-living amebas: Balamuthia mandrillaris, Acanthamoeba spp., and Naegleria fowleri. J. Eukaryot. Microbiol. 2006, 53:121-126.
70. Arnalich-Montiel F., et al. Successful monitoring and treatment of intraocular dissemination of Acanthamoeba with voriconazole. J. Arch. Ophthalmol. 2012, 130:1474-1475.
71. Tu E.Y., et al. Polymicrobial keratitis: Acanthamoeba and infectious crystalline keratopathy. Am. J. Ophthalmol. 2009, 148:13-19.
72. Kitzmann A.S., et al. Keratoplasty for treatment of Acanthamoeba keratitis. Ophthalmology 2009, 116:864-869.
73. Nguyen T.H., et al. Penetrating keratoplasty in active Acanthamoeba keratitis. Cornea 2010, 29:1000-1004.
74. Parthasanrathy A., Tan D.T.H. Deep lamellar keratoplasty for Acanthamoeba keratitis. Cornea 2007, 26:1021-1023.
75. Roberts C.W., Henriquez F.L. Drug target identification, validation, characterisation and exploitation for treatment of Acanthamoeba (species) infections. Exp. Parasitol. 2010, 126:91-96.
76. Aichelburg A.C., et al. Successful treatment of disseminated Acanthamoeba sp infection with miltefosine. Emerg. Infect. Dis. 2008, 14:1743-1746.
77. Campochiaro P.A. Potential applications for RNAi to probe pathogenesis and develop new treatments for ocular disorders. Gene Ther. 2006, 13:559-562.
78. Rondinone C.M. Therapeutic potential of RNAi in metabolic diseases. Biotechniques 2006, 40:31-36.
79. Martín-Navarro C.M., et al. Inhibition of HMG-CoA reductase and the application of statins as a novel effective therapeutic approach against Acanthamoeba infections. Antimicrob. Agents Chemother. 2013, 57:375-381.